From top 300 pharma brands, Centre has expanded scope of QR code packaging to entire ranges of vaccines, anti-cancer medicines, antimicrobials, and narcotic and psychotropic drugs.
India’s drug regulator approved Zaynich on 27 May, ahead of US FDA decision. Science behind it isn’t just medically significant but also unusually innovative for a field largely running dry.
Study conducted by 13 organisations found that in govt hospitals, direct median total cost for treating bloodstream infections triggered by antimicrobial-resistant bacteria was Rs 89,377.
Developed by Mumbai-based Wockhardt, it will be available under brand name Miqnaf. Administering it once-a-day for 3 days could be significant in addressing drug-resistant pneumonia.
Study by scientists associated with ICMR, Cambridge University and Christian Medical College (CMC), Vellore, was published Tuesday in the Journal of Epidemiology and Global Health.
This new proposal, being considered by CDSCO, comes in response to concerns over antimicrobial resistance emerging as a massive public health challenge across the globe, including in India.
In a seminal work, former military officers Lt. Gen. D.S. Hooda & Lt. Col. Pavithran Rajan put forth a framework to approach cognitive warfare, called Socio-Technical-Cognitive Battlespace.
India, China and Russia share more contradictions than congruence. Each has a different worldview, as also a different adversary. The rude fact is that BRICS is the most irrelevant of all such groupings.
COMMENTS